The significant efficacy of DR17 observed in both Pten-Pb-Cre mouse model and xenograft models of prostate cancer suggests that DR17 delivered by micelles can reach both the normal organ site (prostate) and the ectopic sites in xenografts. The gene discussed is PTEN; the disease is prostate cancer.